Hanmi Pharm. Co., Ltd. (128940.KS), Thursday announced third-quarter financial results, reporting net profit of KRW 45.4 billion compared to KRW 35 billion in 2024.
Pre-tax profit amounted to KRW 52.3 billion compared to KRW 40.2 billion in the previous year.
Operating profit was KRW 55.1 billion compared to last year's KRW 51 billion.
Sales stood at KRW 362.3 billion compared to KRW 362.1 billion in the year ago quarter.
Hanmi's stock closed at KRW 390,500, down 0.76 percent on the Korea Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.